Objective: To determine if a dextrose-saline solution manufactured und
er commercial conditions and containing 1 IU per ml of heparin prolong
s the use of infusion sites in children. Design: Double-blind randomiz
ed trial. Patients: Eight children in a medical ward. Outcome Measures
: Failure of infusion sites from phlebitis and/or extravasation. Inter
vention: Duration of use of infusion sites was calculated to the neare
st hour. Statistics: Univariate survival analysis. Results: The median
time to failure when solutions contained the heparin (97 hours) was s
ignificantly increased (p < 0.0001) compared with control solutions (4
3 hours). Conclusions: Use of solutions containing low-dose heparin is
recommended for children who might have problems with venous access.